Carmell To Sell Its Axolotl Biologix Subsidiary For 3,845,337 Shares Of Carmell Common Stock, 4,243 Shares Of Carmell Preferred Stock And Notes Payable To The Initial Sellers In The Aggregate Amount Of $8M
Carmell To Sell Its Axolotl Biologix Subsidiary For 3,845,337 Shares Of Carmell Common Stock, 4,243 Shares Of Carmell Preferred Stock And Notes Payable To The Initial Sellers In The Aggregate Amount Of $8M
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.